Your browser is no longer supported. Please, upgrade your browser.
Settings
AMPE Ampio Pharmaceuticals, Inc. daily Stock Chart
AMPE [AMEX]
Ampio Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.11 Insider Own8.65% Shs Outstand166.39M Perf Week-2.85%
Market Cap146.55M Forward P/E- EPS next Y-0.09 Insider Trans0.00% Shs Float162.49M Perf Month-12.81%
Income-16.10M PEG- EPS next Q-0.02 Inst Own12.30% Short Float10.99% Perf Quarter3.77%
Sales- P/S- EPS this Y-122.50% Inst Trans1.91% Short Ratio4.65 Perf Half Y55.60%
Book/sh0.04 P/B20.52 EPS next Y18.20% ROA-127.50% Target Price- Perf Year83.34%
Cash/sh0.03 P/C30.53 EPS next 5Y- ROE-341.50% 52W Range0.26 - 1.39 Perf YTD40.79%
Dividend- P/FCF- EPS past 5Y29.60% ROI- 52W High-41.23% Beta1.57
Dividend %- Quick Ratio2.70 Sales past 5Y- Gross Margin- 52W Low214.19% ATR0.07
Employees23 Current Ratio2.70 Sales Q/Q- Oper. Margin- RSI (14)45.02 Volatility4.99% 8.56%
OptionableYes Debt/Eq0.00 EPS Q/Q-563.60% Profit Margin- Rel Volume0.19 Prev Close0.82
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume3.84M Price0.82
Recom2.00 SMA20-7.13% SMA50-0.65% SMA20020.89% Volume650,998 Change-0.48%
Dec-19-19Initiated ROTH Capital Buy $4
Mar-17-14Reiterated Aegis Capital Buy $15 → $16
Sep-25-12Initiated Aegis Capital Buy $11
Oct-08-20 09:15AM  
Sep-21-20 09:15AM  
Sep-14-20 09:15AM  
Sep-09-20 09:15AM  
Sep-04-20 09:15AM  
Aug-19-20 08:00AM  
Jul-31-20 02:43PM  
Jul-23-20 08:00AM  
Jul-20-20 08:00AM  
Jun-29-20 11:31AM  
Jun-19-20 08:00AM  
May-22-20 08:00AM  
May-21-20 06:45AM  
May-11-20 08:00AM  
Apr-16-20 08:37AM  
Apr-02-20 10:41AM  
09:00AM  
Mar-24-20 07:00AM  
06:30AM  
Feb-21-20 06:30AM  
Dec-23-19 07:57PM  
Dec-04-19 08:30AM  
Oct-10-19 08:30AM  
Sep-18-19 08:30AM  
Sep-17-19 08:30AM  
Aug-22-19 08:30AM  
Jul-25-19 08:30AM  
Jul-11-19 08:30AM  
Jul-10-19 08:30AM  
Jun-19-19 04:01PM  
Jun-17-19 08:16AM  
Jun-14-19 04:01PM  
07:30AM  
May-22-19 08:30AM  
Apr-29-19 08:00AM  
Mar-26-19 07:34PM  
Mar-06-19 08:30AM  
Feb-25-19 07:40AM  
Feb-06-19 08:30AM  
Dec-13-18 06:00AM  
Nov-26-18 08:30AM  
Nov-07-18 04:45PM  
08:30AM  
Oct-30-18 12:23PM  
Oct-25-18 08:55AM  
Oct-24-18 03:10PM  
12:00PM  
Oct-23-18 04:33PM  
03:55PM  
11:55AM  
10:00AM  
Oct-22-18 05:10PM  
04:25PM  
01:15PM  
11:40AM  
Oct-21-18 10:30PM  
06:00PM  
02:00PM  
11:00AM  
Oct-20-18 01:50PM  
07:00AM  
Oct-19-18 06:26PM  
05:05PM  
05:00PM  
02:20PM  
01:24PM  
12:01PM  
10:29AM  
Oct-18-18 03:15PM  
11:31AM  
Oct-17-18 04:25PM  
03:07PM  
01:45PM  
01:30PM  
12:00PM  
Oct-16-18 07:46PM  
02:10PM  
11:45AM  
10:00AM  
Oct-15-18 04:30PM  
Oct-14-18 10:00AM  
Oct-12-18 07:05PM  
02:00PM  
01:00PM  
Oct-11-18 05:25PM  
02:30PM  
Oct-10-18 09:25PM  
07:19PM  
02:59PM  
01:35PM  
10:00AM  
Oct-09-18 02:54PM  
12:00PM  
Oct-08-18 06:38PM  
Oct-07-18 10:15AM  
Oct-05-18 06:59PM  
05:19PM  
Oct-04-18 06:18PM  
10:00AM  
08:30AM  
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. It is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds. The company's product pipeline includes Ampion, which is in phase III clinical trial, is an intra-articular injection for the treatment of osteoarthritis of the knee. Ampio Pharmaceuticals, Inc. is headquartered in Englewood, Colorado.